1. Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R. Increased prevalence of tension-type headache over a 12-year period is related to increased pain sensitivity. A population study. Cephalalgia 2007; 27: 145–52.
2. Burstein R, Yarnitsky D, Goor-Aryeh I et al. An association between migraine and cutaneous allodynia. Ann Neurol 2000; 47: 614–24.
3. Cakit BD, Taskin S, Nacir B et al. Comorbidity of fibromyalgia and cervical myofascial pain syndrome. Clin Rheumatol 2010; 29: 405–11.
4. Campbell JN, Raja SN, Meyer RA, Mackinnon SE. Myelinated afferents signalthe hyperalgesia associated with nerve injury. Pain 1988; 32: 89–94.
5. Chiang CY, Li Z, Dostrovsky JO, Sessle BJ. Central sensitization in medullary dorsal horn involves gap junctions and hemichannels. Neuroreport 2010; 21: 233–7.
6. Crofford LJ, Rowbotham MC, Mease PJ et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52 (4): 1264–73.
7. Dahl JB, Mathiesen O, Kehlet H. An expert opinion on postoperative painmanagement, with special reference to new developments. Expert Opin Pharmacother 2010; 11: 2459–70.
8. De Tommaso M, Sardaro M, Serpino C et al. Fibromyalgia comorbidity in primary headaches. Cephalalgia 2009; 29: 453–64.
9. Dimcevski G, Staahl C, Andersen SD et al. Assessment of experimental pain from skin, muscle, and esophagus in patients with chronic pancreatitis. Pancreas 2007; 35: 22–9.
10. Drewes AM, Pedersen J, Reddy H et al. Central sensitization in patients with non-cardiac chest pain: a clinical experimental study. Scand J Gastroenterol 2006; 41: 640–9.
11. Dworkin RH, O’Connor AB, Audette J et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85: S3–S14.
12. Filatova E, Latysheva N, Kurenkov A. Evidence of persistent central sensitization in chronic headaches: a multi-method study. J Headache Pain 2008; 9: 295–300.
13. Foster DC, Dworkin RH, Wood RW. Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted women. Pain 2005; 117: 128–36.
14. Goncalves DA, Bigal ME, Jales LC et al. Headache and symptoms of temporomandibular disorder: an epidemiological study. Headache 2010; 50: 231–41.
15. Gwilym SE, Keltner JR, Warnaby CE et al. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum 2009; 61: 1226–34.
16. Hogeweg JA, Kuis W, Huygen AC et al. The pain threshold in juvenile chronic arthritis. Br J Rheumatol 1995; 34: 61–7.
17. Ifergane G, Buskila D, Simiseshvely N et al. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 2006; 26: 451–6.
18. Jorum E, Warncke T, Stubhaug A. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine–a double-blind, cross-over comparison with alfentanil and placebo. Pain 2003; 101: 229–35.
19. Khan AA, Owatz CB, Schindler WG et al. Measurement of mechanical allodynia and local anesthetic efficacy in patients with irreversible pulpitis and acute periradicular periodontitis. J Endod 2007; 33: 796–9.
20. Kupers R, Schneider FC, Christensen R et al. No evidence for generalized increased postoperative responsiveness to pain: a combined behavioral and serial functional magnetic resonance imaging study. Anesth Analg 2009; 109: 600–6.
21. Lorenz J, Grasedyck K, Bromm B. Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephalogr Clin Neurophysiol 1996; 100: 165–8.
22. Lundblad H, Kreicbergs A, Jansson KA. Prediction of persistent pain after total knee replacement for osteoarthritis. J Bone Joint Surg Br 2008; 90: 166–71.
23. Riedl A, Schmidtmann M, Stengel A et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 2008; 64: 573–82.
24. Rodriguez MA, Afari N, Buchwald DS. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol 2009; 182: 2123–31.
25. Scholz J, Mannion RJ, Hord DE et al. A novel tool for the assessment of pain: validation in low back pain. PLoS Med 2009; 6: e1000047.
26. Schwartzman RJ, Alexander GM, Grothusen JR et al. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain 2009; 147: 107–15.
27. Shibata K, Yamane K, Iwata M. Change of excitability in brainstem and cortical visual processing in migraine exhibiting allodynia. Headache 2006; 46: 1535–44.
28. Staud R. Are patients with systemic lupus erythematosus at increased risk for fibromyalgia? Curr Rheumatol Rep 2006; 8: 430–5.
29. Staud R, Nagel S, Robinson ME, Price DD. Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain 2009; 145: 96–104.
30. Straube S, Derry S, Moore R, McQuay H. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. Pheumatology 2010; 49: 706–15.
31. Tietjen GE, Brandes JL, Peterlin BL et al. Allodynia in migraine: association with comorbid pain conditions. Headache 2009; 49: 1333–44.
32. Turini D, Beneforti P, Spinelli M et al. Heat/burning sensation induced by topical application of capsaicin on perineal cutaneous area: new approach in diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome? Urology 2006; 67: 910–3.
33. Wiesinger B, Malker H, Englund E, Wanman A. Back pain in relation to musculoskeletal disorders in the jaw-face: a matched case-control study. Pain 2007; 131: 311–9.
34. Wilder-Smith CH, Robert-Yap J. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome. World J Gastroenterol 2007; 13: 3699–704.
35. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983; 306: 686–8
36. Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004; 140: 441–51.

А.Б.Данилов, Ю.М.Курганова 

ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздравсоцразвития РФ